Cardinal Health, Inc. $CAH Shares Sold by Allianz Asset Management GmbH

Key Points

• Allianz Asset Management GmbH reduced its holdings in Cardinal Health by 17.2%, resulting in ownership of 714,393 shares valued at approximately $120 million.
• Insiders have recently sold a total of 271,676 shares worth around $40 million, indicating significant insider selling activity.
• Cardinal Health reported an earnings per share (EPS) of $2.08 for the last quarter, exceeding analyst expectations, despite revenues falling short of forecasts.

Allianz Asset Management GmbH trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 17.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 714,393 shares of the company's stock after selling 148,315 shares during the quarter. Allianz Asset Management GmbH owned approximately 0.30% of Cardinal Health worth $120,018,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CAH. GAMMA Investing LLC increased its position in shares of Cardinal Health by 28.4% during the first quarter. GAMMA Investing LLC now owns 7,004 shares of the company's stock worth $965,000 after purchasing an additional 1,549 shares in the last quarter. Assenagon Asset Management S.A. increased its position in shares of Cardinal Health by 25.8% during the first quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock worth $1,811,000 after purchasing an additional 2,694 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in Cardinal Health by 15.1% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 35,790 shares of the company's stock valued at $4,931,000 after buying an additional 4,693 shares in the last quarter. Sagespring Wealth Partners LLC purchased a new stake in Cardinal Health in the 1st quarter valued at $233,000. Finally, Insigneo Advisory Services LLC purchased a new stake in Cardinal Health in the 1st quarter valued at $285,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CAH has been the subject of several analyst reports. Morgan Stanley restated an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Wells Fargo & Company restated an "overweight" rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Robert W. Baird increased their price target on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a report on Wednesday, August 13th. Leerink Partners increased their price target on Cardinal Health from $186.00 to $187.00 and gave the stock an "outperform" rating in a report on Monday, October 6th. Finally, Evercore ISI lowered their price target on Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $166.00.

Insider Buying and Selling at Cardinal Health

In other news, insider Michelle D. Greene sold 13,500 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares of the company's stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ola M. Snow sold 28,151 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Price Performance

CAH stock opened at $155.72 on Thursday. The firm has a market capitalization of $37.00 billion, a P/E ratio of 24.14, a P/E/G ratio of 1.30 and a beta of 0.71. The business's 50-day moving average is $151.90 and its two-hundred day moving average is $151.48. Cardinal Health, Inc. has a 1 year low of $106.98 and a 1 year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health's revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter last year, the company earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were given a $0.5107 dividend. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.